Viventia Biotech Inc. Report issue

For profit Phase 1 Phase 3
Founded: Winnipeg Canada (1995)
Status: Acquired by Sesen Bio (2016) → now Carisma Therapeutics (2022)

Organization Overview

First Clinical Trial
2005
NCT00412776
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Novopharm Ltd | Viventia Bio